Matches in Wikidata for { <http://www.wikidata.org/entity/Q65384759> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65384759 description "clinical trial" @default.
- Q65384759 description "ensayu clínicu" @default.
- Q65384759 description "klinisch onderzoek" @default.
- Q65384759 description "клінічне випробування" @default.
- Q65384759 name "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 name "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 type Item @default.
- Q65384759 label "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 label "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 prefLabel "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 prefLabel "Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir" @default.
- Q65384759 P1132 Q65384759-88AA5268-DEBC-4ECA-9798-7420C49720DC @default.
- Q65384759 P1476 Q65384759-6AA999FF-8D61-4B7F-A3BF-860C712D5196 @default.
- Q65384759 P17 Q65384759-01433ABD-0A7B-4A20-A1A6-58B87156B55F @default.
- Q65384759 P17 Q65384759-14BD448F-7AD4-41C2-95C2-E4B988F04A61 @default.
- Q65384759 P17 Q65384759-562D5BD2-4577-449C-B7D4-98B7F0A130AB @default.
- Q65384759 P17 Q65384759-652C0970-7C6D-4A71-B616-0F40484F7EF7 @default.
- Q65384759 P17 Q65384759-7CFD327B-842C-4CEA-B451-C329654ECD0F @default.
- Q65384759 P17 Q65384759-80C50CE0-A2A6-48F5-9894-970954DF97F2 @default.
- Q65384759 P17 Q65384759-9E35A31E-9404-4C3C-B421-66FD1DF77C0D @default.
- Q65384759 P17 Q65384759-AB41A7F4-7C1B-4B66-B5A3-7E1E0F3D3DA6 @default.
- Q65384759 P17 Q65384759-AF86826F-F4F4-4EC6-A240-89828DAE6F15 @default.
- Q65384759 P17 Q65384759-CFD20216-B214-4562-9D51-C1E345962904 @default.
- Q65384759 P1813 Q65384759-989F328F-F1A3-48E9-98E6-4E3A6587AB1E @default.
- Q65384759 P2899 Q65384759-ACE356DF-637D-4E63-842A-626B8BC1568A @default.
- Q65384759 P3098 Q65384759-1701FCD6-74C8-4B7C-BAEC-ABECD39DD7CF @default.
- Q65384759 P31 Q65384759-BB35DDC2-8B81-4A2F-B8CC-FA7D6D2BFF9A @default.
- Q65384759 P4844 Q65384759-6A627F51-4C3D-4C31-A2FB-B36446AAB422 @default.
- Q65384759 P580 Q65384759-9ECB45DF-F2FA-4F26-8C34-6AD89082C8EE @default.
- Q65384759 P582 Q65384759-24EE81E4-65B7-4D15-9292-BA5BB0EFD42C @default.
- Q65384759 P6099 Q65384759-28D403B5-7EB8-4830-A825-5CD6CDF5F4A5 @default.
- Q65384759 P8363 Q65384759-E31E25B4-DA48-40DD-8EA8-FADC2B0A5B5E @default.
- Q65384759 P1132 "+256" @default.
- Q65384759 P1476 "A Randomised, Controlled, Open-label Trial to Compare the Efficacy, Safety and Tolerability of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg O.D. vs a Triple Combination Therapy With DRV/r in HIV-1 Infected Patients With Undetectable Plasma HIV-RNA on Their Current Treatments." @default.
- Q65384759 P17 Q145 @default.
- Q65384759 P17 Q183 @default.
- Q65384759 P17 Q28 @default.
- Q65384759 P17 Q29 @default.
- Q65384759 P17 Q31 @default.
- Q65384759 P17 Q35 @default.
- Q65384759 P17 Q39 @default.
- Q65384759 P17 Q40 @default.
- Q65384759 P17 Q45 @default.
- Q65384759 P17 Q801 @default.
- Q65384759 P1813 "MONET" @default.
- Q65384759 P2899 "+18" @default.
- Q65384759 P3098 "NCT00458302" @default.
- Q65384759 P31 Q30612 @default.
- Q65384759 P4844 Q3765251 @default.
- Q65384759 P580 "2007-06-01T00:00:00Z" @default.
- Q65384759 P582 "2009-02-01T00:00:00Z" @default.
- Q65384759 P6099 Q42824827 @default.
- Q65384759 P8363 Q78089383 @default.